Letter to the editor re: “Diabetes-specific formulas high in monounsaturated fatty acids and metabolic outcomes in patients with diabetes or hyperglycaemia. A systematic review and meta-analysis”
Publication date: 5 January 2021Source: Journal of Hazardous Materials, Volume 401Author(s): Man Cheng, Yun Zhou, Bin Wang, Ge Mu, Jixuan Ma, Min Zhou, Dongming Wang, Meng Yang, Limin Cao, Li xie, Xing Wang, Xiuquan Nie, LingLing Yu, Jing Yuan, Weihong Chen
Publication date: Available online 4 July 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Petar Radanliev, David De Roure, Rob Walton
Publication date: Available online 4 July 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Hrishikesh Korada, Arun Maiya, Sharath Kumar Rao, Manjunath Hande
Publication date: Available online 4 July 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Anggi Lukman Wicaksana, Nuzul Sri Hertanti, Astri Ferdiana, Raden Bowo Pramono
CONCLUSION: The presence of diabetes, craniotomy and acute kidney injury may inform the conversation surrounding chances for decannulation prior to tracheostomy. PMID: 32615825 [PubMed - as supplied by publisher]
The coronavirus pandemic has made it even more difficult to manage chronic diseases such as diabetes and high blood pressure, diseases that disproportionately affect Black people
Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit: https://www.fightaging.org/newsletter/ Longevity Industry Consulting Services Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out m...
This report summarizes the possibility of endothelial cell loss in diabetic patients. A decrease in endothelial cell density (ECD) in diabetic patients has been reported. In addition, corneal thickness may increase in diabetic patients. Significant endothelial cell loss has been demonstrated in long-term disease and in cases of poor metabolic control. No association between the use of oral hypoglycemics and ECD has been reported. There is also no evidence of an association between the use of insulin and corneal endothelial damage. No difference in ECD among the various degrees of retinopathy or with a history of photocoagu...
The drink may also be protective against type 2 diabetes and metabolic syndrome. → Support PsyBlog for just $5 per month. Enables access to articles marked (M) and removes ads. → Explore PsyBlog's ebooks, all written by Dr Jeremy Dean: Accept Yourself: How to feel a profound sense of warmth and self-compassion The Anxiety Plan: 42 Strategies For Worry, Phobias, OCD and Panic Spark: 17 Steps That Will Boost Your Motivation For Anything Activate: How To Find Joy Again By Changing What You Do
Conclusions: The majority of CHC patients had comorbidities; almost all patients took multiple prescribed medications, the number of which increased with age, and significant DDI risk was present in 97% of this Korean patient cohort. Comorbidities and comedication profiles should be considered during DAA therapy. PMID: 32616682 [PubMed - as supplied by publisher]